NO20060675L - Forbedrede, rekombinante, humane interferon-beta-lb-polypeptider - Google Patents

Forbedrede, rekombinante, humane interferon-beta-lb-polypeptider

Info

Publication number
NO20060675L
NO20060675L NO20060675A NO20060675A NO20060675L NO 20060675 L NO20060675 L NO 20060675L NO 20060675 A NO20060675 A NO 20060675A NO 20060675 A NO20060675 A NO 20060675A NO 20060675 L NO20060675 L NO 20060675L
Authority
NO
Norway
Prior art keywords
polypeptides
recombinant human
human interferon
interferon beta
ifn
Prior art date
Application number
NO20060675A
Other languages
English (en)
Inventor
Erno Pungor
Eirik Nestass
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20060675L publication Critical patent/NO20060675L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Foreliggende oppfinnelse vedrører rekombinante, humane interferon-p-lb ("IFN-P-lb")-polypeptider eller fragmenter, analoger, derivater eller varianter derav, som har forbedret spesifikk aktivitet. Foreliggende oppfinnelse vedrører også farmasøytiske preparater som omfatter slike IFN-P-lb-polypeptider eller fragmenter, analoger, derivater eller varianter derav, som er nyttige for å behandle multiple sklerose. Foreliggende oppfinnelse vedrører videre fremgangsmåter for å fremstille slike IFN-P-lbpreparater.
NO20060675A 2003-07-11 2006-02-10 Forbedrede, rekombinante, humane interferon-beta-lb-polypeptider NO20060675L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48665703P 2003-07-11 2003-07-11
PCT/US2004/021618 WO2005016371A1 (en) 2003-07-11 2004-07-06 IMPROVED RECOMBINANT HUMAN INTERFERON-BETA-1b POLYPEPTIDES

Publications (1)

Publication Number Publication Date
NO20060675L true NO20060675L (no) 2006-04-06

Family

ID=34193062

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060675A NO20060675L (no) 2003-07-11 2006-02-10 Forbedrede, rekombinante, humane interferon-beta-lb-polypeptider

Country Status (15)

Country Link
US (1) US20050008616A1 (no)
EP (1) EP1646397B1 (no)
JP (1) JP2007530419A (no)
KR (1) KR20060034286A (no)
CN (1) CN100408090C (no)
AU (1) AU2004264855A1 (no)
BR (1) BRPI0412477A (no)
CA (1) CA2528514A1 (no)
ES (1) ES2393783T3 (no)
IL (2) IL172269A0 (no)
MX (1) MXPA06000460A (no)
NO (1) NO20060675L (no)
RU (1) RU2006104023A (no)
WO (1) WO2005016371A1 (no)
ZA (1) ZA200601236B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008507297A (ja) * 2004-07-26 2008-03-13 エンゾン ファーマシューティカルズ，インコーポレーテッド 最適化されたインターフェロンβ遺伝子
EP1909822B1 (en) 2005-06-29 2013-09-25 Yeda Research And Development Co., Ltd. Recombinant interferon alpha 2 (ifn alpha 2) mutants
AU2008247815B2 (en) 2007-05-02 2012-09-06 Ambrx, Inc. Modified interferon beta polypeptides and their uses
CA2707840A1 (en) 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
EP2207890A4 (en) * 2007-10-05 2010-12-15 Barofold Inc HIGH PRESSURE PROCESSING OF AGGREGATED INTERFERONS
CN103898123B (zh) * 2012-12-28 2019-03-15 北京韩美药品有限公司 重组人IFN-β-1a及其生产和纯化方法
CN108841793B (zh) * 2018-06-08 2021-08-27 东北农业大学 抗鸭Mx-A单克隆抗体及其在检测鸭Mx蛋白的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5326859A (en) 1979-10-30 1994-07-05 Juridical Foundation, Japanese Foundation For Cancer Research DNA and recombinant plasmid
IL90047A (en) * 1982-10-19 1992-12-01 Cetus Oncology Corp Cysteine-depleted biologically active muteins other than interferon - '
US4588585A (en) * 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4572798A (en) * 1984-12-06 1986-02-25 Cetus Corporation Method for promoting disulfide bond formation in recombinant proteins
US5814485A (en) * 1995-06-06 1998-09-29 Chiron Corporation Production of interferon-β (IFN-β) in E. coli
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano

Also Published As

Publication number Publication date
CA2528514A1 (en) 2005-02-24
MXPA06000460A (es) 2006-04-07
EP1646397B1 (en) 2012-08-22
WO2005016371A8 (en) 2006-06-15
ZA200601236B (en) 2007-05-30
CN1822852A (zh) 2006-08-23
EP1646397A1 (en) 2006-04-19
JP2007530419A (ja) 2007-11-01
IL172269A0 (en) 2006-04-10
KR20060034286A (ko) 2006-04-21
CN100408090C (zh) 2008-08-06
IL207422A0 (en) 2010-12-30
ES2393783T3 (es) 2012-12-28
RU2006104023A (ru) 2006-07-27
BRPI0412477A (pt) 2006-09-19
US20050008616A1 (en) 2005-01-13
AU2004264855A1 (en) 2005-02-24
WO2005016371A1 (en) 2005-02-24

Similar Documents

Publication Publication Date Title
ATE466085T1 (de) Protease-resistente modifizierte interferon alpha polypeptide
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
EA200800159A1 (ru) РЕКОМБИНАНТНЫЕ МУТАНТЫ ИНТЕРФЕРОНА α2 (IFNα2)
NO20060675L (no) Forbedrede, rekombinante, humane interferon-beta-lb-polypeptider
MY140710A (en) Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
MXPA03000626A (es) Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de la hepatitis c.
MXPA03000627A (es) Nuevos peptidos como inhibidores de proteasa serina-ns3 del virus de la hepatitis c.
BR0208150A (pt) Antagonistas de mch e sua aplicação no tratamento da obesidade
ATE348883T1 (de) Zusammensetzungen und verfahren mit analogen von g-csf
WO2000077216A3 (en) Porcine circovirus vaccine in recombinant poxvirus
TWI265927B (en) Novel compounds as NS3-serine protease inhibitors of hepatitis C virus
WO2002008256A3 (en) Peptides as ns3-serine protease inhibitors of hepatitis c virus
EA200702656A1 (ru) Составы, содержащие пептиды, стимулирующие рецептор эритропоэтина, и их применение
DK0861261T3 (da) Nukleotid- og proteinsekvenser af hvirveldyrs-Delta-gener og fremgangsmåder baseret derpå
DK1427708T3 (da) Amino-phthalazinon-derivater som kinase-inhibitorer, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger der indeholder det samme
DK0950096T3 (da) Anti-invasive og anti-angiogene urokinase-fragmenter og deres anvendelse
WO2001016330A3 (en) Prevention of affections associated with porcine circovirus-2
MXPA02011545A (es) Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela.
MXPA04003858A (es) Antagonistas de mch para el tratamiento de obesidad.
HRP20050585A2 (en) Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof
EA200900373A1 (ru) Реконструированные сурфактанты, обладающие улучшенными свойствами
MX2020013296A (es) Composiciones que contienen inhibidor de proteasa recombinante, metodos para producir las mismas y usos de las mismas.
BR0211761A (pt) depsipeptìdeos e processos para preparar os mesmos
ATE540971T1 (de) Proteinkinase-c-inhibitoren zur prävention von insulinresistenz und typ-2-diabetes
TW200501963A (en) Pharmaceutical compositions comprising epinastine for the treatment of skin diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application